Warren Buffett's Successor, Greg Abel, Cashed Out on UnitedHealth. But Is the Stock a Steal at Its Current Valuation?

Greg Abel, Berkshire Hathaway's new CEO, sold the company's entire 5 million+ share position in UnitedHealth Group earlier this year, reversing Warren Buffett's purchase from the previous year. Despite the sale, UnitedHealth has made significant recovery progress through cost management, pricing adjustments, and AI investments. At 23x forward earnings, the stock is reasonably priced and considered a solid long-term healthcare holding, though not an absolute steal.